Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Dose Finding And Efficacy Study Of Angiomax® (Bivalirudin) As Primary Anticoagulation In Infants Under Six Months With Thrombosis

NCT00043277 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT00043277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00043277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Dose Finding And Efficacy Study Of Angiomax® (Bivalirudin) As Primary Anticoagulation In Infants Under Six Months With Thrombosis
Lead sponsor
The Medicines Company
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2002
Completion date
December 31, 2004
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombosis